Starting hemodialysis with catheter and mortality risk: Persistent association in a competing risk analysis

Journal of Vascular Access

Volumn 17, Issue 1, 2016, Pages 20-28

  Roca Tey, Ramon ^a,b   Arcos, Emma ^c   Comas, Jordi ^c   Cao, Higini ^c,d   Tort, Jaume ^c   Catalonian Renal Registry Committee, ^c  

^a Coordinator of the Vascular Accesses Working Group of the Catalan Society of Nephrology ^*  (Spain)

^b Hospital de Mollet   (Spain)

^c Health Department of Catalonia   (Spain)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

Catheter; Fistula; Hemodialysis; Mortality risk; Vascular access

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERIOVENOUS GRAFT; ARTICLE; BLOOD VESSEL GRAFT; CARDIOVASCULAR MORTALITY; DIALYSIS CATHETER; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; RISK ASSESSMENT; TUNNELED CENTRAL CATHETER; UNTUNNELED CENTRAL CATHETER; VASCULAR ACCESS; ADOLESCENT; ADVERSE EFFECTS; ARTERIOVENOUS SHUNT; BLOOD VESSEL TRANSPLANTATION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEVICES; INDWELLING CATHETER; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84956925785     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000468     Document Type: Article

References (38)

1. Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465-473.
2. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009; 53(3):475-491.
3. Perl J, Wald R, McFarlane P, et al. Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol. 2011;22(6):1113-1121.
4. Quinn RR, Ravani P. Fistula-first and catheter-last: fading certainties and growing doubts. Nephrol Dial Transplant. 2014; 29(4):727-730.
5. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477-486.
6. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J; CHOICE Study. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005; 16(5):1449-1455.
7. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ; HEMO study group. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006; 47(3):469-477.
8. Moist LM, Trpeski L, Na Y, Lok CE. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol. 2008;3(6):1726-1732.
9. Lacson E Jr, Wang W, Lazarus JM, Hakim RM. Change in vascular access and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2009;54(5):912-921.
10. Gruss E, Portolés J, Tato A, et al. Clinical and economic repercussions of the use of tunneled haemodialysis catheters in a health area. Nefrologia. 2009;29(2):123-129.
11. Ocak G, Halbesma N, le Cessie S, et al. Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant. 2011; 26(8):2611-2617.
12. Antón-Pérez G, Pérez-Borges P, Alonso-Almán F, Vega-Díaz N. Vascular accesses in haemodialysis: a challenge to be met. Nefrologia. 2012;32(1):103-107.
13. DeSilva RN, Patibandla BK, Vin Y, et al. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol. 2013;24(8):1297-1304.
14. Nordio M, Tessitore N, Feriani M, et al. Scientific Committee of Veneto Dialysis and Transplantation Registry. Mortality in the Veneto population on renal replacement therapy. J Nephrol. 2013;26(Suppl 20):S23-S33.
15. Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2(1):89-99.
16. Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ. Early mortality in patients starting dialysis appears to go unregistered. Kidney Int. 2014;86(2):392-398.
17. Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85(1):158-165.
18. The International Classification of Diseases. 9th Revision, Clinical Modification 1978. Comission on Professional and Hospital Activities, Ann Harbor, Michigan 48705, USA.
19. van Dijk PC, Jager KJ, de Charro F, et al. ERA-EDTA registry. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16(6):1120-1129.
20. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
21. Bray BD, Boyd J, Daly C, et al. Scottish Renal Registry. Vascular access type and risk of mortality in a national prospective cohort of hemodialysis patients. Q J Med. 2012;105(11): 1097-1103.
22. Mauri JM, Clèries M, Vela E, Registry CR. Catalan Renal Registry. Design and validation of a model to predict early mortality in haemodialysis patients. Nephrol Dial Transplant. 2008; 23(5):1690-1696.
23. Catalan Society of Nephrology. Mortality risk calculator: predictive model of mortality within one year after starting HD. Available online at: http://www.socane.cat. Accessed December 24, 2014.
24. U.S. Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.
25. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar- Zadeh K. Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol. 2012;35(6): 548-558.
26. Lok CE, Mokrzycki MH. Prevention and management of catheter- related infection in hemodialysis patients. Kidney Int. 2011; 79(6):587-598.
27. Xue H, Ix JH, Wang W, et al. Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis. 2013;61(1):123-130.
28. Canaud B, Sénécal L, Leray-Moragués H, et al. L’accès vasculaire, une cause d’inflammation sous-estimée chez l’hémodialysé. Nephrologie. 2003;24(7):353-358.
29. Cappelli G, Tetta C, Canaud B. Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant. 2005;20(2):266-270.
30. Movilli E, Brunori G, Camerini C, et al. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif. 2006; 24(4):387-393.
31. Hung AM, Alp Ikizler TA. Hemodialysis central venous catheters as a source of inflammation and its implications. Semin Dial. 2008;21(5):401-404.
32. Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC. Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int. 2009;76(10):1063-1069.
33. Sachdeva M, Hung A, Kovalchuk O, Bitzer M, Mokrzycki MH. The initial vascular access type contributes to inflammation in incident hemodialysis patients. Int J Nephrol. 2012;2012: 917465.
34. Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014;64(6):954-961.
35. Roca-Tey R, Arcos E, Comas J, Cao H, Tort J, Committee CR. Vascular access for incident hemodialysis patients in Catalonia: analysis of data from the Catalan Renal Registry (2000-2011). J Vasc Access 2015. doi: 10.5301/jva.5000410 [Epub ahead of print].
36. Roca Tey R. Vascular access for haemodialysis: an unresolved issue. Nefrologia. 2010;30(3):280-287.
37. Grubbs V, Wasse H, Vittinghoff E, Grimes BA, Johansen KL. Health status as a potential mediator of the association between hemodialysis vascular access and mortality. Nephrol Dial Transplant. 2014;29(4):892-898.
38. Bradbury BD, Chen F, Furniss A, et al. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis. 2009; 53(5):804-814.